Dr William Wallace Anderson, MD in Rio Rancho, NM - Medicare General Practice

Dr William Wallace Anderson, MD is a medicare enrolled "Family Medicine" physician in Rio Rancho, New Mexico. He went to University Of Utah School Of Medicine and graduated in 1975 and has 49 years of diverse experience with area of expertise as General Practice. He is a member of the group practice Omni Medical Group Llc and his current practice location is 1400 Barbara Loop Se Ste A, Rio Rancho, New Mexico. You can reach out to his office (for appointments etc.) via phone at (505) 892-9711.

Dr William Wallace Anderson is licensed to practice in New Mexico (license number 78-105) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1194800334.

Contact Information

	Dr William Wallace Anderson, MD
	1400 Barbara Loop Se Ste A, Rio Rancho, NM 87124-1088
	(505) 892-9711
	(505) 892-5206

Physician's Profile

Full Name	Dr William Wallace Anderson
Gender	Male
Speciality	General Practice
Experience	49 Years
Location	1400 Barbara Loop Se Ste A, Rio Rancho, New Mexico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr William Wallace Anderson attended and graduated from University Of Utah School Of Medicine in 1975

NPI Data:

NPI Number: 1194800334
Provider Enumeration Date: 10/26/2006
Last Update Date: 08/17/2018

Medicare PECOS Information:

PECOS PAC ID: 4789871476
Enrollment ID: I20101207000863

Medical Identifiers

Medical identifiers for Dr William Wallace Anderson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194800334	NPI	-	NPPES
85-0455201	Other	NM	FEDID
850455201	Other	NM	DEFAULT NUMBER
17418	Medicaid	NM

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	78-105 (New Mexico)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Omni Medical Group Llc	6709049745	7

News Archive

Study reveals how M. tuberculosis escapes death in macrophages

The bacteria that cause the devastating disease tuberculosis have the ability to escape destruction and grow after they are engulfed by lung macrophages, the immune cells that are supposed to destroy pathogens.

Selumetinib demonstrates clinical benefit for patients with metastatic uveal melanoma

The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented on Saturday, June 1, at the 49th annual meeting of the American Society of Clinical Oncology.

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

HUYA Bioscience International, Founder, CEO & Executive Chair, Dr. Mireille Gillings today announced that the Ministry of Health, Labour and Welfare granted HBI-8000 orphan drug designation in Japan for peripheral T-cell lymphoma (PTCL).

Researchers develop new technique to fabricate injectable electronic scaffolds

It's a notion that might be pulled from the pages of science-fiction novel - electronic devices that can be injected directly into the brain, or other body parts, and treat everything from neurodegenerative disorders to paralysis.

New study to evaluate drug combination treatment for uveitis

Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £2.5 million by the National Institute for Health Research (NIHR).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr William Wallace Anderson allows following entities to bill medicare on his behalf.

Entity Name	Omni Medical Group Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1568768042 PECOS PAC ID: 6709049745 Enrollment ID: O20120531000416

News Archive

Study reveals how M. tuberculosis escapes death in macrophages

Selumetinib demonstrates clinical benefit for patients with metastatic uveal melanoma

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

Researchers develop new technique to fabricate injectable electronic scaffolds

New study to evaluate drug combination treatment for uveitis

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr William Wallace Anderson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr William Wallace Anderson, MD 1400 Barbara Loop Se Ste A, Rio Rancho, NM 87124-1088 Ph: (505) 892-9711	Dr William Wallace Anderson, MD 1400 Barbara Loop Se Ste A, Rio Rancho, NM 87124-1088 Ph: (505) 892-9711

News Archive

Study reveals how M. tuberculosis escapes death in macrophages

Selumetinib demonstrates clinical benefit for patients with metastatic uveal melanoma

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

Researchers develop new technique to fabricate injectable electronic scaffolds

New study to evaluate drug combination treatment for uveitis

Family Medicine Doctors in Rio Rancho, NM

Lana K Wagner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4100 High Resort Blvd Se, Pmg Rio Rancho High Resort 4100, Rio Rancho, NM 87124 Phone: 505-462-8520 Fax: 505-462-8510
Jasmine Valerie Gutierrez, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4005 High Resort Blvd Se, Rio Rancho, NM 87124 Phone: 505-462-6000
Dr. Santiago Marinez Ayala, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Grande Blvd Se, Suite A, Rio Rancho, NM 87124 Phone: 505-896-7100
Mrs. Christina Marie Hannah, PA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 184 Unser Blvd Ne, Rio Rancho, NM 87124 Phone: 505-896-0928
Paul Afek, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3001 Broadmoor Blvd Ne, Rio Rancho, NM 87144 Phone: 505-994-7397
Ethan A Prairie, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4005 High Resort Blvd Se, Rio Rancho, NM 87124 Phone: 505-462-6000
J. Dayton Voorhees, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4005 High Resort Blvd Se, Pmg High Resort 4005, Rio Rancho, NM 87124 Phone: 505-462-6000 Fax: 505-462-6006

Dr William Wallace Anderson, MD - Medicare General Practice in Rio Rancho, NM

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Study reveals how M. tuberculosis escapes death in macrophages

Selumetinib demonstrates clinical benefit for patients with metastatic uveal melanoma

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

Researchers develop new technique to fabricate injectable electronic scaffolds

New study to evaluate drug combination treatment for uveitis

Medicare Reassignments

Study reveals how M. tuberculosis escapes death in macrophages

Selumetinib demonstrates clinical benefit for patients with metastatic uveal melanoma

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

Researchers develop new technique to fabricate injectable electronic scaffolds

New study to evaluate drug combination treatment for uveitis

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study reveals how M. tuberculosis escapes death in macrophages

Selumetinib demonstrates clinical benefit for patients with metastatic uveal melanoma

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

Researchers develop new technique to fabricate injectable electronic scaffolds

New study to evaluate drug combination treatment for uveitis

Family Medicine Doctors in Rio Rancho, NM